uniQure (QURE) Acquisitions (2022)
uniQure (QURE) posted quarterly Acquisitions of $1.1 million for Q3 2022, up 31.14% quarter-over-quarter from $822000.0 in Q1 2022.
Powered by 
Analysis
uniQure (QURE) Acquisitions (2022) Analysis & Trends
uniQure's Acquisitions history runs 1 years deep, the most recent figure standing at $1.1 million for Q3 2022.
- In Q3 2022, Acquisitions changed N/A year-over-year to $1.1 million; the TTM figure through Dec 2022 stood at $1.9 million (changed N/A YoY), while the FY2022 annual figure was $1.9 million, down 96.2% from the prior year.
- Acquisitions for Q3 2022 stood at $1.1 million, up from $822000.0 in the prior quarter.
- The five-year high for Acquisitions was $1.1 million in Q3 2022, with the low at $822000.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |